文献速递肝病

2011-2018年美国代谢功能障碍相关脂肪性肝病患病率趋势

Trends in the Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in the United States, 2011-2018.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-01-22

该文基于国际专家共识提出的代谢功能障碍相关脂肪性肝病(MAFLD)命名与定义,描述了美国成人中MAFLD的患病率。原文指出NAFLD影响全球超过25%的成人,但异质性定义和不准确术语导致患病率估计存在差异,MAFLD命名能更全面纳入代谢紊乱。

要点

  • MAFLD命名由国际专家共识提出,旨在更准确反映复杂多系统代谢紊乱。
  • NAFLD影响全球超过25%的成人,与显著临床和经济负担相关。
  • 原文基于新命名与定义描述美国成人MAFLD患病率。

核心结论

  • 原文基于新提出的MAFLD命名与定义描述美国成人患病率,但未报告具体数值。

研究设计与样本

  • 原文为基于美国成人的患病率描述性研究,具体样本量未报告。

主要发现

  • 原文指出NAFLD影响全球超过25%的成人,并关联显著临床和经济负担。
  • 原文提及异质性定义和不准确术语导致患病率估计存在差异。

关键数值与推荐

  • 国际专家小组共识提出了MAFLD更新命名及相关标准。
  • MAFLD命名尚未取代NAFLD,但因更全面纳入代谢紊乱而受到积极接受。

临床怎么用

  • MAFLD命名可能更便于临床医生识别脂肪肝患者。
  • 原文提示MAFLD更全面纳入导致脂肪肝风险的代谢紊乱。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nonalcoholic fatty liver disease (NAFLD) affects more than 25% of the adult population worldwide and is associated with significant clinical and economic burden.1 However, heterogeneous definitions and inaccurate terminology contribute to variations in prevalence estimates and may not comprehensively incorporate complex metabolic dysfunctions that exist. An international expert panel consensus proposed updated nomenclature, metabolic dysfunction-associated fatty liver disease (MAFLD), and associated criteria to more accurately capture this complex multisystem metabolic disorder.2 Although it has not replaced NAFLD, the term MAFLD has been positively received given it more comprehensively incorporates the metabolic derangements that contribute to risk of fatty liver and it may be more practical for clinicians to identify patients with fatty liver.3 We describe prevalence of MAFLD among US adults based on these recently proposed nomenclature and definition.2.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Wong RJ, Cheung R. Trends in the Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in the United States, 2011-2018. Clin Gastroenterol Hepatol. 2021. PMID: 33493692. doi:10.1016/j.cgh.2021.01.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。